Joshpharm Limited - Accounts to registrar (filleted) - small 17.3

Joshpharm Limited - Accounts to registrar (filleted) - small 17.3


IRIS Accounts Production v17.3.1.106 06547725 Board of Directors 1.6.16 31.5.17 31.5.17 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure065477252016-05-31065477252017-05-31065477252016-06-012017-05-31065477252015-05-31065477252015-06-012016-05-31065477252016-05-3106547725ns14:PoundSterling2016-06-012017-05-3106547725ns10:Director12016-06-012017-05-3106547725ns10:PrivateLimitedCompanyLtd2016-06-012017-05-3106547725ns10:SmallEntities2016-06-012017-05-3106547725ns10:AuditExempt-NoAccountantsReport2016-06-012017-05-3106547725ns10:SmallCompaniesRegimeForDirectorsReport2016-06-012017-05-3106547725ns10:SmallCompaniesRegimeForAccounts2016-06-012017-05-3106547725ns10:AbridgedAccounts2016-06-012017-05-310654772512016-06-012017-05-3106547725ns10:OrdinaryShareClass12016-06-012017-05-3106547725ns10:Director22016-06-012017-05-3106547725ns10:CompanySecretary12016-06-012017-05-3106547725ns10:RegisteredOffice2016-06-012017-05-3106547725ns5:CurrentFinancialInstruments2017-05-3106547725ns5:CurrentFinancialInstruments2016-05-3106547725ns5:ShareCapital2017-05-3106547725ns5:ShareCapital2016-05-3106547725ns5:RetainedEarningsAccumulatedLosses2017-05-3106547725ns5:RetainedEarningsAccumulatedLosses2016-05-3106547725ns5:NetGoodwill2016-06-012017-05-3106547725ns5:IntangibleAssetsOtherThanGoodwill2016-06-012017-05-3106547725ns5:FurnitureFittings2016-06-012017-05-3106547725ns5:ComputerEquipment2016-06-012017-05-3106547725ns5:DeferredTaxation2016-05-3106547725ns5:DeferredTaxation2017-05-3106547725ns10:OrdinaryShareClass12017-05-3106547725ns5:RetainedEarningsAccumulatedLosses2016-05-3106547725ns5:RetainedEarningsAccumulatedLosses2016-06-012017-05-31


REGISTERED NUMBER: 06547725















Unaudited Financial Statements for the Year Ended 31 May 2017

for

Joshpharm Limited

Joshpharm Limited (Registered number: 06547725)






Contents of the Financial Statements
for the Year Ended 31 May 2017




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


Joshpharm Limited

Company Information
for the Year Ended 31 May 2017







DIRECTORS: Mr S B Joshi
Mrs D S Joshi





SECRETARY: Mrs D S Joshi





REGISTERED OFFICE: Transport House
Uxbridge Road
Hillingdon Heath
Middlesex
UB10 0LY





REGISTERED NUMBER: 06547725






Joshpharm Limited (Registered number: 06547725)

Abridged Balance Sheet
31 May 2017

31.5.17 31.5.16
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 266,750 291,000
Tangible assets 5 2,743 3,658
269,493 294,658

CURRENT ASSETS
Stocks 40,447 38,935
Debtors 90,446 99,313
Cash at bank and in hand 262,005 208,926
392,898 347,174
CREDITORS
Amounts falling due within one year 396,023 384,282
NET CURRENT LIABILITIES (3,125 ) (37,108 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

266,368

257,550

PROVISIONS FOR LIABILITIES 6 732 732
NET ASSETS 265,636 256,818

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 8 265,536 256,718
SHAREHOLDERS' FUNDS 265,636 256,818

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2017.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2017 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the
Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at
the end of each financial year and of its profit or loss for each financial year in accordance with the
requirements of Sections 394 and 395 and which otherwise comply with the requirements of the
Companies Act 2006 relating to financial statements, so far as applicable to the company.

Joshpharm Limited (Registered number: 06547725)

Abridged Balance Sheet - continued
31 May 2017


The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 May 2017 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 26 February 2018 and were signed on
its behalf by:





Mr S B Joshi - Director


Joshpharm Limited (Registered number: 06547725)

Notes to the Financial Statements
for the Year Ended 31 May 2017

1. STATUTORY INFORMATION

Joshpharm Limited is a private company, limited by shares , registered in Not specified/Other. The
company's registered number and registered office address can be found on the Company Information
page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts,
rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2008, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured
at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for
obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement,
except to the extent that it relates to items recognised in other comprehensive income or directly in
equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been
enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at
the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods
different from those in which they are recognised in financial statements. Deferred tax is measured
using tax rates and laws that have been enacted or substantively enacted by the year end and that are
expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable
that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Joshpharm Limited (Registered number: 06547725)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2017

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the
company's pension scheme are charged to profit or loss in the period to which they relate.

Financial instruments
Financial instruments are classified and accounted for according to the substance of the contractual
arrangement,as either financial assets,financial liabilities or equity instruments.An equity instrument is
any contract that evidences a residual interest in the assets of the company after deducting all of its
liabilities.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 .

4. INTANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 June 2016
and 31 May 2017 485,000
AMORTISATION
At 1 June 2016 194,000
Amortisation for year 24,250
At 31 May 2017 218,250
NET BOOK VALUE

At 31 May 2017 266,750
At 31 May 2016 291,000

5. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 June 2016
and 31 May 2017 24,840
DEPRECIATION
At 1 June 2016 21,182
Charge for year 915
At 31 May 2017 22,097
NET BOOK VALUE
At 31 May 2017 2,743
At 31 May 2016 3,658

6. PROVISIONS FOR LIABILITIES
31.5.17 31.5.16
£    £   
Deferred tax 732 732

Joshpharm Limited (Registered number: 06547725)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2017

6. PROVISIONS FOR LIABILITIES - continued

Deferred
tax
£   
Balance at 1 June 2016 732
Excess of capital allowance
over depreciation
Balance at 31 May 2017 732

7. CALLED UP SHARE CAPITAL


Allotted, issued and fully paid:
Number: Class: Nominal 31.5.17 31.5.16
value: £    £   
100 Ordinary 1 100 100

8. RESERVES
Retained
earnings
£   

At 1 June 2016 256,718
Profit for the year 68,818
Dividends (60,000 )
At 31 May 2017 265,536

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

Ar 31 May 2017 the balance owing to the directors of the company was £279,718 (2016 - £272,542).

10. RELATED PARTY DISCLOSURES

During the financial year, the company paid interim dividends of £60,000 (2016 - £70,000) to the
directors of the company who are also the shareholders of the company.

11. ULTIMATE CONTROLLING PARTY

In the opinion of the directors, there were no ultimate controlling party for the current year and the
previous year.